UCL News

The UK Dementia Trials Network, led by a UCL professor of neurology, is establishing a dedicated nationwide network of Dementia Research Nurses.

The time to carry out diagnostic MRI scans for dementia can be cut to one third of their standard length, according to a new study led by UCL researchers.

World-leading Alzheimer’s disease experts, including UCL scientists, are calling for rapid reform in healthcare systems, public policy, and societal attitudes, in order to fully realise the potential of groundbreaking new medications.

A major UCL-led clinical trial, aiming to transform the diagnosis of Alzheimer’s disease through a simple blood test, is now welcoming its first participants who will be recruited via memory clinics across the UK.

People who exercise throughout their lives have a better chance of avoiding dementia – even if they show signs of diseases like Alzheimer’s, finds a new study led by UCL researchers.

Dr Chris Hardy of UCL’s Dementia Research Centre has been announced as Alzheimer’s Society’s second Carol Jennings Fellow.

In the last year UCL’s staff, students and alumni have continued to change the world with their research, innovation and achievements. From making key discoveries in dementia and cancer research, to building bonds overseas and even winning multiple Nobel Prizes.

A loss of brain volume associated with new immunotherapies for Alzheimer’s disease may be caused by the removal of amyloid plaques, rather than the loss of neurons or brain tissue, finds a study led by UCL researchers.

The Medicines and Healthcare Products Regulatory Agency (MHRA) has licensed the immunotherapy drug, Lecanemab, for use in the early stages of Alzheimer’s disease in the UK, following decades of work supported by UCL research.

A new BBC documentary, The Jennings vs Alzheimer’s, explores the discoveries made by researchers at UCL and UCLH that have given hope for Alzheimer’s disease over the past four decades, and the very special family that helped make it happen.

Head of clinical trials at the UCL Dementia Research Centre, Dr Cath Mummery, has been announced as the Director of a new network of dementia trial sites across the country.

UCL’s new world-class neuroscience building has reached its highest point in construction, which was celebrated with a ‘topping out’ ceremony today.

UCL’s Professor Sir John Hardy was the first to identify the role of amyloid in Alzheimer’s disease - now, three decades later, that finding has resulted in a drug that may help patients.

The new drug lecanemab shows promise to one day treat Alzheimer's disease, but there's still a long way to go before it can be an effective and easily available treatment, writes Professor Jonathan Schott (UCL Queen Square Institute of Neurology) in The Guardian.

By estimating people’s brain age from MRI scans using machine learning, a team led by UCL researchers has identified multiple risk factors for a prematurely ageing brain.